APA (7th ed.) Citation

Jin, Y., Inoue, Y., Shimada, H., Hara, T., Yamashita, S., Yamamoto, M., & Matsubara, O. (2026). Feasibility Study of Intratumoral NRF2 Expression as a Predictive Biomarker for the Effectiveness of Immunotherapy in Patients with Non-Small Cell Lung Cancer Treated with PD-1 Inhibitor. Cancers, 18(14), 2202. https://doi.org/10.3390/cancers18142202

Chicago Style (17th ed.) Citation

Jin, Yasuto, Yukihisa Inoue, Hiroyuki Shimada, Tetsu Hara, Shohei Yamashita, Mio Yamamoto, and Osamu Matsubara. "Feasibility Study of Intratumoral NRF2 Expression as a Predictive Biomarker for the Effectiveness of Immunotherapy in Patients with Non-Small Cell Lung Cancer Treated with PD-1 Inhibitor." Cancers 18, no. 14 (2026): 2202. https://doi.org/10.3390/cancers18142202.

MLA (9th ed.) Citation

Jin, Yasuto, et al. "Feasibility Study of Intratumoral NRF2 Expression as a Predictive Biomarker for the Effectiveness of Immunotherapy in Patients with Non-Small Cell Lung Cancer Treated with PD-1 Inhibitor." Cancers, vol. 18, no. 14, 2026, p. 2202, https://doi.org/10.3390/cancers18142202.